# Scientific Industries Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Scientific Industries Inc). ## Overview Scientific Industries Inc. designs, manufactures, and markets benchtop laboratory equipment and bioprocessing systems through its operating subsidiaries in the United States and Germany. Its products are used in laboratory-scale research and bioprocessing workflows across academic, pharmaceutical, healthcare, and industrial research settings. ## Products & services • Benchtop laboratory equipment • Genie brand laboratory mixers and shakers • Torbal laboratory and OEM products • Bioprocessing systems and products • DOTS new product development - **Benchtop Laboratory Equipment** (60%) — Standard laboratory instruments sold for research and routine lab workflows, including Genie and Torbal products. - **Bioprocessing Systems** (35%) — Systems and products used in bioprocessing and laboratory-scale process development. - **OEM and Specialty Laboratory Products** (5%) — Custom or OEM-oriented Torbal products and related laboratory equipment offerings. - Benchtop laboratory equipment - Genie brand laboratory mixers and shakers - Torbal laboratory and OEM products - Bioprocessing systems and products - DOTS new product development ## Customers The company sells primarily to research-oriented institutions and organizations that need compact laboratory equipment or bioprocessing tools for experimentation and development. Its customer base includes universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industrial research users. - **Universities and academic research labs** (primary) — Buy benchtop instruments and bioprocessing tools for teaching, experimentation, and research programs. - **Pharmaceutical companies** (primary) — Purchase laboratory equipment and bioprocessing systems for drug research and development workflows. - **National laboratories** (secondary) — Use specialized benchtop equipment for controlled research and testing applications. - **Medical device manufacturers** (secondary) — Buy lab-scale instruments for product development, validation, and testing. - **Pharmacies and other industrial research users** (secondary) — Purchase compact laboratory equipment for applied research and formulation work. - Universities buying lab equipment for academic research - Pharmaceutical companies using tools for R&D and process work - National laboratories needing bench-scale research instruments - Medical device manufacturers running laboratory testing workflows - Pharmacies and other research users with small-scale lab needs ## Geography Scientific Industries is headquartered in the United States and operates through U.S. and German subsidiaries, giving it a transatlantic manufacturing and commercial footprint. The available filings identify the U.S. and Germany as core operating locations, with products sold into research markets that can be sensitive to funding cycles, trade conditions, and cross-border supply costs. - **United States** (70%) — Estimated from U.S. headquarters and primary customer base - **Europe** (30%) — Estimated from German subsidiary and international research sales - United States is the main operating and customer market - Germany is an operating base through aquila biolabs GmbH - Cross-border structure supports bioprocessing product development - Trade conditions can affect input costs for laboratory products - Research funding cycles influence demand across geographies ## Strategy The company’s strategy centers on maintaining a portfolio of benchtop laboratory equipment while developing bioprocessing systems and new products through its Scientific Bioprocessing platform. It also appears to rely on product development, OEM relationships, and international operating capabilities to broaden its research-market reach. - **Expand bioprocessing product development** (medium-term) — New products can broaden the addressable market beyond legacy benchtop equipment. - **Support the core benchtop equipment franchise** (short-term) — Established laboratory products provide the base customer relationships and operating cash generation. - **Leverage international operating structure** (medium-term) — The German subsidiary can support product development, sourcing, and sales into European research markets. - Support core benchtop equipment franchise - Develop bioprocessing systems and DOTS products - Use Torbal and OEM channels to diversify sales - Maintain international operating capability through Germany - Balance legacy products with new research tools ## Risks Demand depends on research budgets, customer funding, and the timing of lab purchasing decisions, which can make revenue uneven. The company also faces tariff exposure, trade-war uncertainty, and product-development risk because it sells specialized instruments with some components and OEM inputs subject to cost pressure and launch timing uncertainty. - **Reduced research funding** [high] — Customers in academia and research-heavy industries may delay or reduce equipment purchases when budgets tighten. - **Global trade war and tariff exposure** [high] — Imported components and OEM products can become more expensive, pressuring gross margin and pricing. - **Product development and launch timing** [medium] — Bioprocessing revenue depends on customer acceptance and availability of new products. - **Customer order delays** [medium] — Specialized instruments are often purchased after funding approvals or technical finalization, creating timing volatility. - Research funding cuts can delay customer purchases - Trade-war uncertainty can weaken order timing and demand - Tariffs can raise material costs for OEM and lab products - New product delays can postpone bioprocessing revenue - Small-company scale increases sensitivity to sales swings ## Accounting Revenue and operating results can be affected by the timing of customer orders, product shipment, and acceptance in specialized laboratory markets. Investors should also watch estimates tied to inventory, fixed overhead absorption, foreign currency translation, and the going-concern assessment, since the company discloses significant judgment around liquidity and recoverability. - **Revenue recognition timing** — Can shift quarterly revenue and comparability - **Inventory valuation and overhead absorption** — Affects gross profit and inventory carrying values - **Foreign currency translation** — Can affect reported earnings and equity - **Going-concern and liquidity judgments** — Can influence financial statement presentation and disclosure - Revenue timing can shift with customer order finalization - Inventory and fixed overhead affect gross profit - Foreign currency translation matters through the German subsidiary - Going-concern assessment depends on liquidity and cash generation - Estimates and assumptions can affect asset recoverability --- *Last updated: 2026-04-29T04:54:43.636680+00:00*